Candace Pert Quantum Experiment
Candace Pert Quantum Experiment
Candace Pert Quantum Experiment
Candace Pert:
A Molecular Jungian
in Search of the Quantum Experiment
Advances: Dr Pert, what are you working on these autism. I’m very interested in autism, and I’m nervous
days? about it. Recently there was a report in the media that
Pert: I’m still working on our AIDS drug that we they’ve now “debunked” the story that the measles-
invented. mumps-rubella or MMR vaccine has a connection to
Advances: This is the drug that is based on neu- autism. These reports are based on epidemiological stud-
ropeptides? ies, and I just can’t believe that any analysis can debunk
Pert: Yes, it was invented for AIDS but then it turned that vaccine connection in the absence of hard science,
out to have other uses, for psoriasis, for example. There’s which is clearly needed.
a whole new breakthrough in our understanding of the Advances: One of the things that I find interesting
drug and how it works. We used to think it worked on about autism is the question of a brain-gut connection,
one receptor, but it turns out that it works on a which seems to be related to your research.
chemokine receptor, which is miraculous, because it’s Pert: It is a well-established, published, scientific fact
been newly discovered that the virus plugs into corecep- that a lot of people with autism also have gut problems.
tors—chemokine receptors—which weren’t even discov- Viruses grow in various tissues in the body, and the gut is
ered yet when peptide T was discovered. If you one place where they stay. I know a lot about viruses
remember, there had been some fussing about whether because this is what I’ve been working on for the last 16
peptide T was for real or whether it was a bunch of years. What’s the difference between an attenuated virus
baloney. It turns out that the main virus that affects peo- that’s used for a vaccine and one that causes disease? In
ple in the early stages of HIV uses these chemokine recep- fact, nobody really knows. Basically, one causes disease
tors to enter and infect cells. Peptide T blocks these and the other doesn’t. Genetically, they’re nearly the same.
receptors and is the first of a new class of AIDS drugs They make the same envelope. It’s astounding that kids
called viral entry inhibitors. born after 1983 (approximately) have these live viruses
We realize now that we could make receptor-active that are maintained, and some of them do grow.
peptide drugs for other conditions, such as Alzheimer’s Viruses take up residence in the gut, and the key is to
disease and autism. We are now seeing very positive have the holistic vision and realize that there is much
antiviral and immunomodulatory results from a clinical more communication between the body systems than we
trial being run in San Francisco by Advanced Immunity, thought. For example, virally infected monocytes can
Inc, and the National Cancer Institute. move throughout the brain and the body. There are many
Advances: These peptides occur in the brain as well? plausible mechanisms for this connection. For one thing,
Pert: Yes, they do, and that’s important because we now know that there are peptides called chemokines
they’re inflammatory peptides and that’s related to that have receptors in the brain and in the immune sys-
tem, among other places, and they mediate inflammation.
No one knows the mechanism, but by giving a lot of vac-
Candace Pert, PhD, is a research professor in the Department
of Physiology and Biophysics at Georgetown University, cines to a kid of a certain age, if you create inflammation,
Washington, DC. She is the author of Molecules of Emotion: I can just imagine that you alter brain development.
The Science Behind Mind-Body Medicine and has directed One possible mechanism could be that these
extensive neuropeptide/receptor research. chemokines, which are released during inflammation,
actually modulate neuronal survival—the number of
Dr Pert was interviewed by Sheldon Lewis, editor of Advances
neurons that survive—as my colleagues and I published
in Mind-Body Medicine.
in a paper 2 years ago. Now there’s a study with rats